| Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk N Bozina, V Bradamante, M Lovric Arhiv za higijenu rada i toksikologiju 60 (2), 217, 2009 | 343 | 2009 |
| Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. N Bozina, P Granić, Z Lalić, I Tramisak, M Lovrić, A Stavljenić-Rukavina Croatian Medical Journal 44 (4), 425-428, 2003 | 176 | 2003 |
| A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics C Mizzi, E Dalabira, J Kumuthini, N Dzimiri, I Balogh, N Başak, R Böhm, ... PloS one 11 (9), e0162866, 2016 | 134 | 2016 |
| The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naive patients with first-episode schizophrenia treated with risperidone N Jovanović, N Božina, M Lovrić, V Medved, M Jakovljević, AM Peleš European journal of clinical pharmacology 66 (11), 1109-1117, 2010 | 122 | 2010 |
| The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood–brain barrier in patients with generalized epilepsy S Basic, S Hajnsek, N Bozina, I Filipcic, D Sporis, D Mislov, A Posavec Seizure 17 (6), 524-530, 2008 | 120 | 2008 |
| Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients N Bozina, MR Kuzman, V Medved, N Jovanovic, J Sertic, L Hotujac Journal of psychiatric research 42 (2), 89-97, 2008 | 118 | 2008 |
| Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study N Mirošević Skvrce, V Macolić Šarinić, I Mucalo, D Krnić, N Božina, ... Croatian medical journal 52 (5), 604-614, 2011 | 106 | 2011 |
| MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression AM Peles, N Bozina, M Sagud, MR Kuzman, M Lovric Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (6), 1439-1444, 2008 | 97 | 2008 |
| The influence of 5-HT2C and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients MR Kuzman, V Medved, N Bozina, L Hotujac, I Sain, H Bilusic Psychiatry research 160 (3), 308-315, 2008 | 81 | 2008 |
| How polymorphisms of the cytochrome P450 genes affect ibuprofen and diclofenac metabolism and toxicity V Krasniqi, A Dimovski, N Božina | 65 | 2016 |
| Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy M Lovric, N Božina, S Hajnšek, MR Kuzman, D Sporiš, Z Lalic, T Božina, ... Therapeutic drug monitoring 34 (5), 518-525, 2012 | 61 | 2012 |
| Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder N Bozina, A Mihaljevic Peles, M Sagud, H Bilusic, M Jakovljevic The world journal of biological psychiatry 9 (3), 190-197, 2008 | 60 | 2008 |
| Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer’s disease? A Knezovic, A Loncar, J Homolak, U Smailovic, J Osmanovic Barilar, ... Journal of neural transmission 124 (6), 695-708, 2017 | 59 | 2017 |
| MDR1polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients M Brinar, S Cukovic-Cavka, N Bozina, KG Ravic, P Markos, A Ladic, ... BMC gastroenterology 13 (1), 57, 2013 | 59 | 2013 |
| Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia MR Kuzman, V Medved, N Bozina, J Grubišin, N Jovanovic, J Sertic The pharmacogenomics journal 11 (1), 35-44, 2011 | 58 | 2011 |
| Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients N Bozina, V Medved, MR Kuzman, I Sain, J Sertic Journal of psychopharmacology 21 (7), 728-734, 2007 | 58 | 2007 |
| Treatment-resistant schizophrenia and DAT and SERT polymorphisms P Bilic, V Jukic, M Vilibic, A Savic, N Bozina Gene 543 (1), 125-132, 2014 | 53 | 2014 |
| The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol M Zivkovic, A Mihaljevic-Peles, N Bozina, M Sagud, M Nikolac-Perkovic, ... Journal of clinical psychopharmacology 33 (5), 593-599, 2013 | 53 | 2013 |
| CYP2C9 and ABCG2 Polymorphisms as Risk Factors for Developing Adverse Drug Reactions in Renal Transplant Patients Taking Fluvastatin: A Case–Control … N Miroševic Skvrce, N Božina, L Zibar, I Barišic, L Pejnovic, ... Pharmacogenomics 14 (12), 1419-1431, 2013 | 53 | 2013 |
| Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population L Ganoci, T Božina, N Mirošević Skvrce, M Lovrić, P Mas, N Božina Drug metabolism and personalized therapy 32 (1), 11-21, 2017 | 52 | 2017 |
